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Abstract
OBJECTIVE: To observe the impact of xinfeng xap-
sule (XFC) on pulmonary function in a rat model of
adjuvant arthritis (AA) and to investigate the mech-
anism of action.
METHODS: Forty rats were randomly divided into
four groups of ten: normal control (NC); model con-
trol (MC); tripterygium glycosides tablet (TPT); and
xinfeng capsule (XFC). Except for the NC group, AA
was induced in all rats by intracutaneous injection
of 0.1 mL Freund's complete adjuvant in the right
paw on the 19th day. NC and MC groups were giv-
en (0.9% ) physiological saline. The TPT and XFC
groups were given TPT (10 mg/kg) and XFC (1.2 g/
kg), respectively. Thirty days after administration,
changes in paw edema (E), the arthritis index (AI),
pulmonary function, levels of regulatory T-cells
(Treg), ultrastructure of lung tissue, and expression
of Notch receptors and ligands in lung tissue were
observed.
RESULTS: In the MC group, E and the AI were in-
creased and pulmonary function significantly de-
creased; the structure of alveolar type-II cells was
damaged; ratios of Treg in peripheral blood were re-
duced; and expression of Notch receptors such as
Notch3 and Notch4 and ligands such as Delta1 in
lung tissue were significantly increased whereas ex-
pression of Notch1, Jagged1 and Jagged2 were sig-
nificantly decreased. After intervention with XFC, E
and the AI were decreased; pulmonary function
was enhanced; the structure of alveolar type-II cells
was improved; and expression of Treg, Notch1, Jag-
ged1, Jagged2 was elevated, whereas that of
Notch3, Notch4 and Delta1 was reduced.
CONCLUSION: XFC can not only inhibit E and the
AI and improve joint symptoms, it can also improve
pulmonary function and reduce inflammation in
lung tissue. These actions could be carried out
through increases in the expression of Treg, Notch
receptors (Notch1) and ligands (Jagged1, Jagged2),
and reductions in the expression of Notch3, Notch4
and Delta1. These phenomena would reduce the
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deposition of immune complexes and the inflam-
matory response in lung tissue, thereby improving
joint symptoms and pulmonary function.
© 2012 JTCM. All rights reserved.
Key words: Arthritis, Experimental; Pulmonary
function; Receptors; Notch; T-Lymphocytes; Regula-
tory; Xinfeng capsule
INTRODUCTION
Rheumatoid arthritis (RA) is a systemic autoimmune
disease. It can lead to cartilage absorption and bone de-
struction. Lung tissue is also vulnerable to the effects of
RA,1 and pulmonary interstitial fibrosis can severely af-
fect the quality of life (QoL) of RA patients.2,3 The
pathogenesis and development of RA are closely relat-
ed to the immune network. Studies have shown that
pulmonary function is significantly reduced, and that
the parameters of pulmonary function and an imbal-
ance of the immune cells are highly correlated in a rat
model of adjuvant arthritis (AA).4,5 A recent study not-
ed that the Notch signaling pathway not only controls
production of immune-cell lineages, but also regulates
further differentiation of peripheral mature immune
cells.6,7 The development of RA also involves the con-
tinuous differentiation of immune cells. Therefore, it
could be speculated that the Notch signaling pathway
may be involved in the pathogenesis of RA and lung le-
sions.
In the present study, the effects of xinfeng capsule
(XFC) on pulmonary function, expression of CD4 +
CD25 + regulatory T cells (Treg) and the Notch path-
way were observed in AA rats. This was undertaken to
explore the mechanism of action of XFC with respect
to improving pulmonary function via cellular immuni-
ty and signaling pathways.
MATERIALS ANDMETHODS
Ethical approval of the study protocol
The study protocol was approved by the Ethics Com-
mittee of Nanjing Medical University (Nanjing, Chi-
na).
Experimental animals
Forty male Sprague-Dawley (SD) rats (180-200 g)
were purchased from the Experimental Animal Center
of Nanjing Medical University (Nanjing, China). All
animals were housed in specific pathogen-free (SPF)
conditions, and had free access to water and standard
rat feed.
Reagents
Freund's complete adjuvant (CFA) was obtained from
Sigma-Aldrich (St Louis, MO, USA). Fluorescein iso-
thiocyanate (FITC)-labeled anti-mouse CD4 monoclo-
nal antibody was purchased from e-Bioscience (San Di-
ego, CA, USA). Phycoerythrin protein (PE)-labeled an-
ti-mouse CD25 monoclonal antibody was obtained
from Biolegend (San Diego, CA, USA). A Reverse
Transcription kit (M-Mulv Reverse), Amplification kit
(PCR Master Mix) were purchased from Fermentas
(Burlington ON, Canada). Notch receptors and ligand
primers were synthesized by Shanghai Biological Engi-
neering Technology Service (Shanghai, China).
Instruments and equipment
A Lung Function Analysis system was provided by
Beilan Bo (Beijing, China). A sensitive Electronic Bal-
ance was from Shanghai Precision Instruments (Shang-
hai, China). A desktop High-speed Refrigerated Centri-
fuge (5417R) was from Eppendorf (Berlin, Germany).
An Ultraviolet-Visible (UV-Vis) Spectrophotometer
(UV-2401PC) was purchased from Shimadzu (Kyoto,
Japan). A PCR Thermal Cycler (T-Gradient Thermob-
lock) was obtained from Biometra (Berlin, Germany).
Electrophoresis apparatus (EPS-301) was from Amer-
sham (Buckinghamshire, UK). Gel Analysis equipment
(Gel Doc-XR) and a Flow Cytometer (Epics XL) were
from Beckman Coulter (Fullerton, CA, USA).
Model replication and administration
Forty male SD rats were divided randomly into four
groups of ten: normal control (NC); model control
(MC); xinfeng capsule (XFC); and tripterygium glyco-
sides tablet (TPT). Except for the NC group, the oth-
ers were injected with 0.1 mL FCA into the right
hindlimb via the intracutaneous route. Administration
was from the 19th day. The NC and MC groups were
given 0.9% (physiological) saline (1 mL/100 g per
day). The TPT and XFC groups were given TPT (10
mg/kg) and XFC (1.2 g/kg), respectively, for 30 days.
Calculation of paw swelling (E) and the arthritis
index (AI)
Paw volume was measured every 3 days. Paw swelling
(E) was calculated8 using the following formula:
E (%)=(Vt-Vn)/Vn×100%
Where Vn and Vt represent the volume of the paw be-
fore and after modeling, respectively.
Systemic and joint disease caused by inflammation was
recorded every 3 days. The AI was classified using a
five-scale method:9 0, no swelling; 1 point, swelling on
the joint of the little toe; 2 points: swelling on the
metatarsal phalange joint and foot; 3 points, swelling
on the hindpaw below ankle swelling; 4 points, swell-
ing on the hindpaw and including ankle swelling. The
sum of points for each rat was calculated, and the high-
est possible score was 12 points.
Evaluation of pulmonary function
Several parameters of pulmonary function were evaluat-
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ed. These included forced vital capacity (FVC) and av-
erage expiratory flow, which was calculated by dividing
FVC by the value for forced expiratory flow in one sec-
ond (FEV1) and multiplying by 100% . Also, 25% ,
50% and 75% of the vital capacity of the peak expira-
tory flow (FEF25, FEF50 and FEF75, respectively) were
calculated. Maximum mid-expiratory flow (MMF),
peak expiratory flow (PEF), and pulmonary dynamic
compliance (Cldyn) were also assessed. These measure-
ments were obtained using the Pulmonary Function
Test apparatus for small animals 30 days after adminis-
tration.
The rats were anesthetized with 10% chloral hydrate
(0.35 mL/100 g; i.p.). Tracheotomy and endotracheal
intubation were then carried out. The rats were put in-
to an airtight box. The ventilator tube was connected
to the mechanical ventilation apparatus to ascertain
pulmonary function. In this determination, external
pressure caused deep inspiration. Computer software
was used to measure each indicator automatically,
quickly and accurately.
Ultrastructural analyses of lung cells
Lung tissue was washed using phosphate-buffered solu-
tion (PBS). It was then cut into pieces (1 mm×1 mm×
1 mm) and fixed in glutaraldehyde (100 mL/L) fol-
lowed by 1% osmium acid. The pieces underwent alco-
hol dehydration, and were then embedded using stan-
dard procedures. Ultrathin sections (50 nm) were
stained with uranyl acetate and lead citrate. All speci-
mens were observed under an electron microscope (×8,
000 magnification), Germany Carl Zeiss (LIBRA120)
and images were taken.
Detection of CD4+CD25+Treg of peripheral blood by
flow cytometry
Fresh blood samples were collected from rats and put
into tubes coated with K3-ethylenediamine tetra-acetic
acid (EDTA). A total of 106 cells per tube were added
to anti-mouse CD4-FITC (0.25 µg) and anti-mouse
CD25-PE (1.0 µg). The mixture was kept in a dark en-
vironment for 20-30 min at room temperature
(20-25°C). Then, 1 mL of red blood cell (RBC) ly-
sate was added to each tube, and the mixture kept in a
dark environment for 15-25 min. After washing twice
with protein blocking agent (PBA) buffer and centrifu-
gation (1500r/min, 5min), washing twice with PBA,
the supernatant was removed and the expression of
CD4+CD25+Treg detected by flow cytometry.
Detection of Notch ligands and receptors of lung
tissue by reverse trancription-polymerase chain
reaction (RT-PCR)
The design and synthesis of primers was based on Gen-
Bank accession numbers for the mRNA sequences.
That is: Notch1 (NM_001105721) Notch2 (NM_
024358), Notch3 (NM_020087), Notch4 (NM_
001002827), Jagged1 (NM_019147), Jagged2 (XM_
001073124) and Delta1 (NM_032063) (Table 1).
Primer Premier 5 software was used for the design and
analysis of the primers.
Table 1 Primer sequences and pre-expansion growth of Notch receptors and ligands
Primer
Notch1
Notch2
Notch3
Notch4
Jagged1
Jagged2
Delta1
Primer sequence
Sense 5′-TCA TCT CCG ACT TCA TCT ATC A-3′
Antisense 5′-TGC AGA GCT GAC TTG CCT A-3′
Sense 5′-ATA GGC TCT AAG GTA TTT CTG G-3′
Antisense 5’-CAA TGC TCG CTT GTC GTG-3’
Sense 5′-CTC TGGTTT CCT GAG GGT TT -3′
Antisense 5′-CCA GTT CGGTCA GTT CGT G -3′
Sense 5′-GGA CTA GGA AAT CCC GAA CC -3′
Antisense 5′-GGC ATC TTT ATC CGC TCC A -3′
Sense 5′-GCT TCG GCT CAG GGT CTA-3′
Antisense 5′-AGT CAC CTG GGA GTT TGC-3′
Sense 5′-GGG CTC TTG CCA CGA AGT-3′
Antisense 5′-AGG CAC GGT TTC CCT TCA-3′
Sense 5′-CCT GAC GAC CTC GCA ACA-3′
Antisense 5′-CAG CTC CCT CCA TTC CTG-3′
Length of pre-amplification (bp)
373
419
497
462
474
222
635
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
was used as the internal reference for the PCR reac-
tions. In each group of samples, the cDNA samples
and PCR-amplification conditions were identical. The
reaction conditions were 95°C for 5 min, then 35 cy-
cles of reaction, with each cycle consisting of denatur-
ation (94°C) for 30 s, annealing for 40 s (Jagged1,
56°C; Jagged2 56°C; Delta1, 58°C; Notch1, 54°C;
Notch2, 55°C; Notch3, 58°C; Notch4, 57°C; diami-
nopimelic acid dehydrogenase (DAPDH), 60° C), ex-
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tension for 60s (72°C) and a final extension at 72°C
for 10 min. Amplification products were separated by
electrophoresis in 1.5% agarose gel containing 0.1 μg/
mL ethidium bromide at 90 V for 65 min. After ethid-
ium-bromide staining, the gel was scanned with a Gel
Scanner. Images were taken with the Gel Image Analyz-
er (Bio-Rad, Hercules, CA, USA). Electrophoretic
bands were analyzed using Image-Pro Plus software.
The ratio of optical density (OD) of the electrophoret-
ic bands of Notch1, Notch2, Notch3, Notch4, Jag-
ged1, Jagged2 and Delta1 to GAPDH was regarded as
an expression of the relative content.
Statistical analyses
Continuous variables are the mean±standard deviation.
All samples were tested to ascertain if they followed a
normal distribution. Data comparison among groups
was carried out using ANOVA. Comparison between
groups was carried out using the independent samples
t-test. SPSS ver13.0 software was used for data analy-
ses. P<0.05 was considered significant.
RESULTS
Changes in paw swelling and the AI in rats
After modeling, at 6 h after inducing inflammation,
the right toes in MC rats began to swell. At the third day
after inducing inflammation, paw swelling reached a
peak and then decreased gradually. Some of the toes in
the forefeet began to show redness and swelling at day 4
and day 5. At day 12, the AI reached a peak, and then de-
clined gradually. Thirty days after inducing inflamma-
tion, compared with the MC group, paw swelling and
the AI decreased in the XFC and TPT groups (P<0.01),
and no significant difference between the XFC group
andTPT group was seen (P>0.05) (Table 2).
Table 2 Effects of XFC on body mass, paw swelling and the arthritis index (n=10, xˉ ±s)
Group
NC
MC
TPT
XFC
Paw swelling (E, % )
Before inflammation
1.62±0.46
1.57±0.52
1.49±0.33
1.52±0.86
After administration
9.87±3.45
20.1±8.46a
11.5±9.73b
15.2±8.89c
Arthritis index (AI, points)
12 d after inflammation
0.18±0.09
1.19±0.94 a
1.14±0.86 a
1.21±0.87 a
After administration
0.32±0.13
8.12±2.15 a
5.06±3.06 b
6.31±2.85 c
Notes: Compared with the MC group, aP<0.01, cP<0.05; compared with the NC group, aP<0.01.
Changes in the parameters of pulmonary function in
rats
Compared with the NC group, parameters of pulmo-
nary function (FEV1, FEF50, FEF75, PEF, Cldyn) were
significantly reduced in the MC group. Values of
FEV1, FEF75, PEF and Cldyn in the TPT and XFC
groups were higher than those in the MC group. Com-
pared with the TPT group, FEF75 and Cldyn were in-
creased in theXFCgroup (P<0.05 orP<0.01) (Table 3).
Changes in CD4+ CD25+ tregs of peripheral blood in
rats
CD4+ CD25+ Tregs of peripheral blood were detected
by flow cytometry. Expression of CD4+ CD25+ Treg in
the MC group was significantly lower compared with
that in the NC group (Figures 2A-B). After interven-
tion of TPT and XFC, the expression of CD4+ CD25+
Tregs of peripheral blood was elevated compared with
that seen in the MC group (P<0.05, Figures 1C-D).
Table 3. Effects of XFC on pulmonary function in rats (n=10, mL/s, xˉ ±s)
Group
NC
MC
TPT
XFC
FEV1
70.4±12.8
49.7±14.7a
64.8±19.6b
66.2±6.64b
FEF25
48.2±16.2
42.7±14.1
43.8±11.3
41.6±19.2
FEF50
44.8±18.4
29.6±16.7 a
37.8±17.1b
35.3±15.5 bc
FEF75
39.2±11.6
21.9±15.3 a
28.7±14.5 b ad
35.6±17.0e
PEF
46.4±14.9
31.4±12.5 a
39.7±16.1 b
37.3±13.4 b
Cldyn
0.37±0.21
0.24±0.16a
0.27±0.52cd
0.33±0.55 b
Notes: FEV1: Forced expiratory flow in one second , FEF25: 25% of the vital capacity of the peak expiratory flow , FEF50: 50% of the vital
capacity of the peak expiratory flow , FEF75: 75% of the vital capacity of the peak expiratory flow , PEF:Peak expiratory flow, Cldyn :
pulmonary dynamic compliance .Compared with the MC group eP<0.01, bP<0.05; compared with the NC group, aP<0.01, cP<0.05;
compared with the XFC group, dP<0.05.
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Figure 1 Expression of CD4+ CD25+ Treg in the peripheral blood of rats (%)
A: NC group; B: MC group; C: TPT group; D: XFC group
Changes in the Notch receptor and ligand mRNA of
rat lung tissue
Compared with the NC group, expression of Notch re-
ceptors Notch3 and Notch4 as well as ligand Delta1
was significantly increased in the MC Group (P<0.05
or P<0.01; Figures 2D-H), but Notch2 expression was
not significantly increased (P>0.05; Figure 2C). Expres-
sion of the receptor Notch1 and ligands Jagged1 and
Jagged2 was significantly decreased (P<0.01; Figures
2B, F and G; Table 3). Thirty days after inducing in-
flammation, compared with the MC group, expression
of Notch receptors Notch3 and Notch4 and ligand
Delta1 was reduced, but expression of Notch1, Jag-
ged1, Jagged2 was elevated in the XFC group. Com-
pared with the TPT group (positive control), expres-
sion of Notch4 and Jagged1 was elevated in the XFC
group (P<0.05; Table 3).
DISCUSSION
How RA can cause lung disease is incompletely under-
stood. Notch signaling plays an important part in lung
damage. Notch signaling has regulatory effects on the
proliferation, differentiation, migration and other bio-
logical activities of alveolar epithelial cells and vascular
endothelial cells through mediation of the expression
of basic helix-loop-helix (bHLH) transcription factor.9
Table 4 Comparison of Notch receptors and ligands of rat lung tissue (n=10, xˉ ±s)
Groups
NC
MC
TPT
XFC
Notch1
0.51±0.25
0.43±0.19 a
0.48±0.36b
0.45±.24
Notch2
0.52±0.31
0.54±0.22
43.8±11.3
41.6±19.2
Notch3
0.43±0.16
0.62±0.39c
0.51±0.27b
0.53±0.35ba
Notch4
0.41±0.18
0.54±0.25 a
0.50±0.24 ad
0.42±17.0b
Jagged1
0.58±0.22
0.33±0.14 c
0.39±0.31 cd
0.48±0.18b
Jagged2
0.56±0.34
0.40±0.21 c
0.49±0.25b
0.47±0.32 a
Delta1
0.49±0.18
0.65±0.34 c
0.58±0.41 a
0.52±0.28b
Notes: Compared with the MC group, bP<0.05; compared with the NC group, cP<0.01, aP<0.05; compared with the XFC group, dP<
0.05.
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Figure 2 Expression of Notch receptor and ligand mRNA in rat lung tissue
A: GAPDH; B: Notch1; C: Notch2; D: Notch3; E: Notch4 ; F: Jagged1; G: Jagged2; H: Delta1. Lanes from left to right: NC group, MC
group, TPT group and XFC group. The unit of amplification is bp.
Studies have shown that, in RA patients with reduced
pulmonary function, Treg expression in peripheral
blood is decreased. Correlation analyses have shown
that in RA patients, pulmonary function is positively
correlated with Treg expression, suggesting that Treg
may be involved in RA-related processes associated
with pulmonary function.10,11 Reduction in the regulato-
ry actions of Treg can cause the formation and deposi-
tion of immune complexes in joints or lung tissue.
This action can activate signal conduction pathways
and form a "waterfall" effect, thereby participating in
lung injury.12,13
Notch is a transmembrane receptor protein family. It
can conduct signals and regulate cell differentiation in
the organism through the interaction of Notch ligands
and receptors. It also has an important role in cell pro-
liferation and apoptosis. There are four Notch recep-
tors (1-4) and five Notch ligands (Delta1, Delta3, Del-
ta4, Jagged1, Jagged2). Neighboring cells can transmit
signals through the binding of Notch ligands and re-
ceptors. Notch can therefore expand the interaction be-
tween cells and determine cell fate.14 Expression of the
ligand on the surface of T-cells and antigen-presenting
cells triggers signal transduction through binding with
receptors, thereby regulating cell development, and
conducting signals among cells.15 Interaction of Notch
ligands Delta1 and Notch can regulate the production
of T- and B-cell lineages, but is also involved in regula-
tion of the differentiation and function of peripheral
mature T-cells and their subsets, which is crucial for de-
termining the differentiation of T lymphocytes.16,17
Common lymphoid precursor cells (CLPs) can be di-
rected towards T-cell differentiation after accepting the
Notch1 signal. If Notch1 is lacking, CLPs develop into
B-cells, without expression in T-cells. However, increas-
es in Notch3 expression can inhibit this process, mak-
ing the precursor cells remain in an undifferentiated
state.18
In the present study, it was found that in AA rats, if
paw edema occurred, parameters of pulmonary func-
tion such as FEV1, FEF50, FEF75, PEF, Cldyn were sig-
nificantly reduced simultaneously. This finding suggest-
ed that that immune complexes were deposited not on-
ly in joints (thereby influencing joint function), but al-
so occurred in other tissues and organs such as lung tis-
sue, inducing decreases in dynamic compliance of lung
tissue, influencing further gas exchange, leading to ven-
tilation disturbance, and a reduction of pulmonary
function. The structure of type-II alveolar epithelial
cells was damaged in AA rats. Expression of the Notch
receptors Notch3 and Notch4 as well as the ligand Del-
ta1 was significantly increased, and that of the receptor
Notch1 and ligands Jagged1 and Jagged2 was signifi-
cantly reduced. In addition, expression of CD4+CD25+
Treg in the peripheral blood of rats was also reduced.
These findings suggested that the abnormal expression
of the Notch signaling pathway may be associated with
a reduction in the number of regulatory T-cells. Notch
signaling may lead to maladjustment of the prolifera-
tion and differentiation of type-II alveolar epithelial
cells. A reduction in the secretion of type-II alveolar ep-
ithelial cells makes the number of pulmonary surfac-
tants decrease. This causes alveoli to collapse gradually,
affecting the ventilation/ventilatory functions of alveo-
li, resulting in decrease in pulmonary function in AA
rats. After intervention with XFC, pulmonary function
improved in XFC-treated rats, whereas expression of
the Notch receptors Notch3 and Notch4 as well as li-
gand Delta1 was reduced, and that of the receptor
Notch1 and ligands Jagged1 and Jagged2 was in-
creased. Expression of CD4 + CD25 + Treg was in-
creased. These findings show that XFC can: increase
the expression of regulatory T-cells; maintain peripher-
al immune tolerance; regulate secretion of cytokines;
inhibit infiltration of lymphocytes and neutrophils and
over-secretion of inflammatory mediators; reduce the
stimulation of inflammation in lung (or joint) tissues;
decrease tension in the alveolar surface; and improve al-
veolar ventilation/ventilatory function. Also, XFC can:
regulate the development of T-lymphocytes and acti-
vate T cells; regulate the immune response of T-cells; re-
duce damage to lung tissue; and improve pulmonary
function in AA rats by up-regulating the expression of
Notch receptor Notch1 and ligands Jagged1 and Jag-
ged2, and down-regulating the expression of Notch3,
Notch4 and Delta1.
In summary, the decrease in pulmonary function in-
duced by RA is closely related to the Notch pathway
and expression of regulatory T-cells. The role of regula-
A B C D
E F G H
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tory T-cells and the Notch pathway in the pathogenesis
of RA is complex. We will study the link between regu-
latory T-cells and the Notch pathway to probe the
mechanism of action of XFC.
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